Form 4 for HCAT Health Catalyst, Inc.

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001562180-23-002427 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-03-03	2023-03-01	HCAT	Freeman Kevin Lee	Chief Commercial Off	A - Grant	$0.00	+3,083	180.9K	+2%	$0
	2023-03-03	2023-03-01	HCAT	Freeman Kevin Lee	Chief Commercial Off	F - Tax	$14.29	-1,569	177.8K	-0.9%	-$22.4K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-01	A	A	1,819	$0.00	179,665	D	—	—	(F2) Represents an award of 1,819 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, the PRSUs noted above vested on March 1, 2023.
2	Common	Common Stock	2023-03-01	F	D	1,569	$14.29	177,846	D	—	—
3	Common	Common Stock	2023-03-01	A	A	1,264	$0.00	180,929	D	—	—	(F3) Represents an award of 1,264 PRSUs pursuant to the 2019 Plan. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, 25% of the PRSUs noted above vested on March 1, 2023 and, thereafter, the remaining 75% of the PRSUs will vest in 12 equal quarterly installments.